← Eichor
Study identifier: NCT04987879 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

NASH AMPK Exercise Dosing (AMPED) Trial

Condition: NAFLD  ·  Sponsor: Milton S. Hershey Medical Center

PhaseNA
Planned participants45
Who can joinAll sexes, 18 Years to 69 Years
Healthy volunteersNo

About this study

There is no known cure or regulatory agency approved drug therapy for nonalcoholic fatty liver disease (NAFLD), the leading cause of liver disease worldwide, and its progressive type, NASH. This places increased importance on using exercise to treat NAFLD. While physical activity is recommended for all with NAFLD, how to best prescribe exercise as a specific treatment remains unknown, including what dose of exercise is most effective.

This description comes directly from the study's public registry record.

Talk to the study team

Breianna L Hummer, MS  ·  7175310003  ·  bhummer@pennstatehealth.psu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Penn State Hershey Medical CenterHershey, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04987879